daratumumab
janssen
['dara ']
looking forward to #asco23 hematologic malignancies-plasma cell dyscrasia session at 1:15pm cdt. &amp; dr godara session chairs. first ever presentation of dual bispecific regimen by dr cohen; a new first in myeloma. #mycompany 
VP of Oncology Global Medical Affairs at Janssen, J&J

Scientist focused on bringing new treatment options for pts with cancer. Tweets/views shared are my own